327 related articles for article (PubMed ID: 18039777)
1. Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b.
Tse PK; Lee YL; Chow WN; Luk JM; Lee KF; Yeung WS
Endocrinology; 2008 Mar; 149(3):1268-76. PubMed ID: 18039777
[TBL] [Abstract][Full Text] [Related]
2. The embryotrophic activity of oviductal cell-derived complement C3b and iC3b, a novel function of complement protein in reproduction.
Lee YL; Lee KF; Xu JS; He QY; Chiu JF; Lee WM; Luk JM; Yeung WS
J Biol Chem; 2004 Mar; 279(13):12763-8. PubMed ID: 14699127
[TBL] [Abstract][Full Text] [Related]
3. Regulation of complement-3 protein expression in human and mouse oviducts.
Lee YL; Cheong AW; Chow WN; Lee KF; Yeung WS
Mol Reprod Dev; 2009 Mar; 76(3):301-8. PubMed ID: 18671285
[TBL] [Abstract][Full Text] [Related]
4. Protection of the classical and alternative complement pathway C3 convertases, stabilized by nephritic factors, from decay by the human C3b receptor.
Fischer E; Kazatchkine MD; Mecarelli-Halbwachs L
Eur J Immunol; 1984 Dec; 14(12):1111-4. PubMed ID: 6240408
[TBL] [Abstract][Full Text] [Related]
5. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
Ezzell JL; Parker CJ
Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
[TBL] [Abstract][Full Text] [Related]
6. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
7. Deposition of C3b and iC3b onto particulate activators of the human complement system. Quantitation with monoclonal antibodies to human C3.
Newman SL; Mikus LK
J Exp Med; 1985 Jun; 161(6):1414-31. PubMed ID: 2409200
[TBL] [Abstract][Full Text] [Related]
8. Trypanosoma brucei Invariant Surface gp65 Inhibits the Alternative Pathway of Complement by Accelerating C3b Degradation.
Lorentzen J; Olesen HG; Hansen AG; Thiel S; Birkelund S; Andersen CBF; Andersen GR
J Immunol; 2023 Sep; 211(5):862-873. PubMed ID: 37466368
[TBL] [Abstract][Full Text] [Related]
9. Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein.
Kim YU; Kinoshita T; Molina H; Hourcade D; Seya T; Wagner LM; Holers VM
J Exp Med; 1995 Jan; 181(1):151-9. PubMed ID: 7528766
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus regulates activation and processing of the third component of complement.
Mold C; Bradt BM; Nemerow GR; Cooper NR
J Exp Med; 1988 Sep; 168(3):949-69. PubMed ID: 2844953
[TBL] [Abstract][Full Text] [Related]
11. Complement component C3 functions as an embryotrophic factor in early postimplantation rat embryos.
Usami M; Mitsunaga K; Miyajima A; Sunouchi M; Doi O
Int J Dev Biol; 2010; 54(8-9):1277-85. PubMed ID: 20712003
[TBL] [Abstract][Full Text] [Related]
12. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
Medof ME; Nussenzweig V
J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies Against C3b-Functional Consequences and Disease Relevance.
Vasilev VV; Radanova M; Lazarov VJ; Dragon-Durey MA; Fremeaux-Bacchi V; Roumenina LT
Front Immunol; 2019; 10():64. PubMed ID: 30761135
[TBL] [Abstract][Full Text] [Related]
14. CCP1-4 of the C4b-binding protein alpha-chain are required for factor I mediated cleavage of complement factor C3b.
Blom AM; Kask L; Dahlbäck B
Mol Immunol; 2003 Jan; 39(10):547-56. PubMed ID: 12431388
[TBL] [Abstract][Full Text] [Related]
15. Structure of C3b in complex with CRIg gives insights into regulation of complement activation.
Wiesmann C; Katschke KJ; Yin J; Helmy KY; Steffek M; Fairbrother WJ; McCallum SA; Embuscado L; DeForge L; Hass PE; van Lookeren Campagne M
Nature; 2006 Nov; 444(7116):217-20. PubMed ID: 17051150
[TBL] [Abstract][Full Text] [Related]
16. Increase in complement iC3b is associated with anti-inflammatory cytokine expression during late pregnancy in mice.
Nakamura K; Kusama K; Bai R; Ishikawa S; Fukushima S; Suda Y; Imakawa K
PLoS One; 2017; 12(5):e0178442. PubMed ID: 28542608
[TBL] [Abstract][Full Text] [Related]
17. Accelerated decay of C3b to iC3b when C3b is bound to the Cryptococcus neoformans capsule.
Pfrommer GS; Dickens SM; Wilson MA; Young BJ; Kozel TR
Infect Immun; 1993 Oct; 61(10):4360-6. PubMed ID: 8406826
[TBL] [Abstract][Full Text] [Related]
18. The low C5 convertase activity of the C4A6 allotype of human complement component C4.
Kinoshita T; Dodds AW; Law SK; Inoue K
Biochem J; 1989 Aug; 261(3):743-8. PubMed ID: 2803239
[TBL] [Abstract][Full Text] [Related]
19. A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
Waldo FB; Forristal J; Beischel L; West CD
J Clin Invest; 1985 Jun; 75(6):1786-95. PubMed ID: 3159752
[TBL] [Abstract][Full Text] [Related]
20. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
Seya T; Okada M; Matsumoto M; Hong KS; Kinoshita T; Atkinson JP
Mol Immunol; 1991 Oct; 28(10):1137-47. PubMed ID: 1833639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
